CSE treatment was able to produce considerable improvement in concentration of IL-1β and LTD-4 in BAL fluid with statistical significance of p < 0.05 and p < 0.01 respectively, after comparing with asthma control group (S) animals. The gene discussed is IL1B; the disease is asthma.